News | March 03, 2014

Hologic's Total Breast Tomosynthesis Solution Featured at ECR

Hologic Total Breast Tomosynthesis Mammography Systems Women's Health

March 3, 2013 — Hologic Inc. is a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. It will showcase its portfolio of products for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria, March 6-10. Hologic is offering three tomosynthesis-related events at ECR.


ECR Satellite Symposium

"Breast Tomosynthesis: Evolution and Adoption Across Europe," March 8, 2-3:30 p.m. in the Austria Center Vienna, Room C. The symposium will feature speakers from various countries throughout Europe, including:

  • Fiona Gilbert, Cambridge, United Kingdom - The use of breast tomosynthesis in the screening assessment in the UK
  • Melcior Sentis, Sabadell, Spain - Using breast tomosynthesis with C-View 2-D images and tomosynthesis guided biopsy: our experience in Spain
  • Francesca Caumo, Verona, Italy - Diagnostic and interventional use of breast tomosynthesis: our experience in Italy
  • Martin Sonnenschein, Bern, Switzerland - The use of breast tomosynthesis with C-View images and tomosynthesis guided biopsy in daily practice: our experience in Switzerland
  • Per Skaane, Oslo, Norway - Incorporating breast tomosynthesis in a population-based screening program: our experience in Oslo


Breast Tomosynthesis Education Sessions

There will be eight 75-minute breast tomosynthesis education sessions from March 7-9. Each session includes hands-on experience reading breast tomosynthesis images in combination with conventional and generated (C-View) 2-D images.


Breast Biopsy Guided by Tomosynthesis Training Workshops 

There will be 14 breast biopsy guided by tomosynthesis training workshops, March 7-9. Each workshop will include an overview of the first clinical experiences with vacuum-assisted breast biopsies guided by tomosynthesis prior to a demonstration of a phantom procedure. There will be time at the end of each session for hands-on training.


Other products on display include:

  • Horizon Bone Densitometry (DXA) System. Shown for the first time in Europe, Hologic's Horizon DXA system provides a single platform for osteoporosis and obesity assessment, visualization of abdominal aortic calcifications and an innovative new feature enabling atypical femur fracture assessment.
  • Selenia Dimensions Avia Package. A cost-effective option for customers seeking a 2-D screening only or 2-D screening and diagnostic solution, this package provides an upgrade pathway for interventional and tomosynthesis capabilities.
  • Fluoroscan InSight-FD Mini C-arm. Featuring flat panel detector technology, this system is designed specifically for orthopedic and extremity surgeons and offers a thin profile and improved workspace access with enhanced ease of positioning.
  • Breast Biopsy Systems. Hologic's Eviva and ATEC breast biopsy systems are designed to conduct minimally invasive biopsy procedures under stereotactic, ultrasound or MRI guidance.


For more information, visit

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init